Skip to main content
Springer logoLink to Springer
. 2019 Apr 27;14(2):136. doi: 10.1007/s11899-019-00506-y

Correction to: Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis: a Review of Current Literature and Future Directions for Transplant Haematologists and Oncologists

Joyutpal Das 1,, Basil Sharrack 2, John A Snowden 3,4
PMCID: PMC6828055  PMID: 31030389

Correction to: Current Hematologic Malignancy Reports

10.1007/s11899-019-00505-z

  • In the 5th paragraph under the section “Efficacy”, the phrase “...reported that NEDA was achieved...” should read as “...reported that cumulative NEDA was achieved...”

  • In the 5th paragraph under the section “Efficacy”, the phrase “...other data suggested that NEDA...” should read as “...other data suggested that yearly NEDA...”

  • In Table 3, the phrase “...likely to significantly higher...” should read as “...likely to be significantly higher...”

  • This information should be added as an article note in the front matter: “Basil Sharrack is a Member of the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT); John A. Snowden is a Chair of the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT).”

The original article has been corrected.

Footnotes

Basil Sharrack is a Member of the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT); John A. Snowden is a Chair of the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT).

The online version of the original article can be found at 10.1007/s11899-019-00505-z

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Joyutpal Das, Email: j.das@doctors.org.uk.

Basil Sharrack, Email: basil.sharrack@sth.nhs.uk.

John A. Snowden, Email: john.snowden@sth.nhs.uk


Articles from Current Hematologic Malignancy Reports are provided here courtesy of Springer

RESOURCES